EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹4,556 Cr | ₹4,254 Cr | ₹3,836 Cr | ₹3,424 Cr | ₹3,717 Cr |
What is the latest Total Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹4,556 Cr |
| Mar2024 | ₹4,254 Cr |
| Mar2023 | ₹3,836 Cr |
| Mar2022 | ₹3,424 Cr |
| Mar2021 | ₹3,717 Cr |
How is Total Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,556 Cr | 7.08 | |
| Mar2024 | ₹4,254 Cr | 10.91 | |
| Mar2023 | ₹3,836 Cr | 12.03 | |
| Mar2022 | ₹3,424 Cr | -7.89 | |
| Mar2021 | ₹3,717 Cr | - | |
Compare Total Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,725.2 Cr | 0.2% | -4.9% | 37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.2% |
-4.9% |
37% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses